london euretina

This meeting has been awarded 20 CME credits

Security Notice

Please note that Kuoni are our only destination management company. Other venders indicating that are operating for the society should be ignored. We never use western union as a payment portal

Posters

The natural history of lamellar macular holes- a spectral domain optical coherence tomography study

Poster Details

First Author: G.Seymenoglu TURKEY

Co Author(s):    F. Ballı   E. Başer               0   0 0   0 0   0 0   0 0

Abstract Details



Purpose:

To study the evolution of lamellar macular holes (LMHs) using spectral domain-optical coherence tomography (SD-OCT).

Setting:

Celal Bayar University Hospital Department of Ophthalmology

Methods:

Thirty-one consecutive patients diagnosed with a LMH were followed prospectively at Celal Bayar University Hospital. Inclusion criteria were a foveal defect on SD-OCT with residual foveal tissue above the retinal pigment epithelium. LMHs were quantitatively and qualitatively characterised by SD-OCT in terms of base and apex diameter and residual foveal thickness. Best corrected visual acuity (BCVA) and SD-OCT findings were collected and compared at baseline and at final examination.

Results:

The patients included 15 males and 16 females with a mean age of 63.9 ± 2.15 years. The mean follow-up period was 21.95 months (range 12-79 months). The mean BCVA (logMAR) at baseline was 0.45±0.18 , and at final examination it was 0.42±0.11 (p>0.05). Residual Foveal thickness at baseline (184,25±31.25 µm), was also stable at the final visit (182±22.36 µm, p>0.05). Moreover, we did not observe statistically significant differences regarding apex (589±82.20 vs 615±93.25 µm, p>0.05) and base (828±76.14 vs 842±80.65 µm, p>0.05) diameters . Any patient developed a full thickness macular hole during the follow-up period.

Conclusions:

Most lamellar macular holes do not progress anatomically and do not contribute to a significant decrease in visual acuity during the follow-up period. Vitrectomy should be considered only in the presence of progressive thinning of foveal thickness and/or decrease of visual acuity during the follow-up of the disease.

Back to previous
EURETINA, Temple House, Temple Road, Blackrock, Co Dublin. | Phone: 00353 1 2100092 | Fax: 00353 1 2091112 | Email: euretina@euretina.org

Privacy policyHotel Terms and Conditions Cancellation policy